Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 44 (3), 269-276

Salivary Interleukin 6, Interleukin 8, Interleukin 17A, and Tumour Necrosis Factor α Levels in Patients With Periodontitis and Rheumatoid Arthritis

Affiliations

Salivary Interleukin 6, Interleukin 8, Interleukin 17A, and Tumour Necrosis Factor α Levels in Patients With Periodontitis and Rheumatoid Arthritis

Tomasz Kaczyński et al. Cent Eur J Immunol.

Abstract

Introduction: Rheumatoid arthritis (RA) and periodontitis share risk factors and inflammatory pathways that could be related to cytokines, such as interleukin (IL)-6, IL-8, IL-17A, and tumour necrosis factor-α (TNF-α). The aim of this study was to compare periodontal status and salivary levels of selected cytokines between patients diagnosed with RA and periodontitis. RA patients were assessed for the potential influence of anti-rheumatic therapy.

Material and methods: One hundred and six patients were enrolled in a cross-sectional study. Medical assessment and periodontal examination were performed in 35 patients with chronic periodontitis, in 35 patients with RA and chronic periodontitis, and in 36 controls. Unstimulated whole saliva samples were analysed for IL-6, IL-8, IL-17A, and TNF-α.

Results: Significant differences in biomarkers and periodontal parameters were found among groups. Study groups exhibited higher mean pocket depth (PD), number of PD > 4 mm, and mean clinical attachment loss, when compared with controls. The RA group had lower bleeding on probing index and PD, but higher values of plaque indices than the periodontitis group. Concentration of evaluated cytokines were higher in the RA and periodontitis groups, compared with controls. The periodontitis group showed also higher levels of IL-6, IL-17A, and TNF-α in comparison to RA. RA patients were treated with disease-modifying anti-rheumatic drugs (DMARDs) and glucocorticosteroids.

Conclusions: Salivary levels of IL-6, IL-8, IL-17A, and TNF-α can be affected by periodontitis, RA, and presumably DMARDs. DMARD therapy appears to reduce destructive and inflammatory processes in periodontal tissues because lower values of PD, BOP, and salivary levels of IL-6, IL-17A, and TNF-α were found in RA.

Keywords: interleukin 17A; interleukin 6; interleukin 8; periodontitis; rheumatoid arthritis; salivary diagnostics; tumour necrosis factor α.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
Box plots of salivary concentrations of IL-6, IL-8, IL-17A, and TNF-α in all three groups

Similar articles

See all similar articles

References

    1. Konopka T, Dembowska E, Pietruska M, et al. Periodontal status and selected parameters of oral condition of Poles aged 65 to 74 years. Przegl Epidemiol. 2015;69:537–542. - PubMed
    1. Kuo LC, Polson AM, Kang T. Associations between periodontal diseases and systemic diseases: a review of the inter-relationships and interactions with diabetes, respiratory diseases, cardiovascular diseases and osteoporosis. Public Health. 2008;122:417–433. - PubMed
    1. Ayravainen L, Leirisalo-Repo M, Kuuliala A, et al. Periodontitis in early and chronic rheumatoid arthritis: a prospective follow-up study in Finnish population. BMJ Open. 2017;7:e011916. - PMC - PubMed
    1. Choi IA, Kim JH, Kim YM, et al. Periodontitis is associated with rheumatoid arthritis: a study with longstanding rheumatoid arthritis patients in Korea. Korean J Intern Med. 2016;31:977–986. - PMC - PubMed
    1. Grasso MA, Comer AC, DiRenzo DD, et al. Using Big Data to Evaluate the Association between Periodontal Disease and Rheumatoid Arthritis. AMIA Annu Symp Proc. 2016;2015:589–593. - PMC - PubMed
Feedback